Key result
Atrial transseptal LV endocardial lead implantation appears feasible and safe after failed coronary sinus approach.
Why the study?
Is endovascular left ventricular lead placement by atrial transseptal approach feasible and safe in patients with previously failed implantation via the coronary sinus?
Case Report (n=1)
Is endovascular left ventricular lead placement by atrial transseptal approach feasible and safe in patients with previously failed implantation via the coronary sinus?
The atrial transseptal approach represents a feasible and safe alternative for left ventricular lead implantation in cardiac resynchronization therapy when the standard coronary sinus approach fails.
Introduction. In patients with cardiac resynchronization therapy left ventricular lead is usually placed through a tributary vein of the coronary sinus. However, when this approach failed, the atrial transseptal approach is mostly used for endovascular left ventricular lead placement, but it is quite difficult to perform. Case report. 59-years-old patient, male, was hospitalized due to endovascular left ventricular lead placement by atrial transseptal approach, after failed attempt via coronary sinus vein. Non-ischemic dilated cardiomiopathy was verified 1 year ago. Endoventricular lead was introduced by left subclavian approach and advanced through the previously punctured hole in the left atrium cavity and over mitral valve placed in posterolateral part of left ventricular. Both right ventricular defibrillator lead and atrial electrode were implanted routinely in the right ventricle septum and right atrial appendage. Conclusion. Left ventricular endocardial lead implantation by atrial transseptal approach is a feasible and safe in patients with previously failed implantation via tributary vein of the coronary sinus.
No takes yet. Share an insight, caveat, or question.
Vukmirović et al. (2016) conducted a case report in Non-ischemic dilated cardiomyopathy (n=1). Atrial transseptal approach for endovascular left ventricular lead placement was evaluated on Feasibility and safety. Left ventricular endocardial lead implantation by atrial transseptal approach was feasible and safe in a 59-year-old male patient after a failed attempt via the coronary sinus vein.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: